Patents by Inventor Paolo DE MARCO

Paolo DE MARCO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SPIROINDOLONE COMPOSITIONS AND METHODS FOR THE TREATMENT OF MALARIA
    Publication number: 20230285430
    Abstract: The present invention is directed to compositions containing spiroindolone compounds, in particular, (1?R,3?S)-5,7?-dichloro-6?-fluoro-3?-methyl-2?,3?,4?,9?-tetrahydrospiro[indoline-3,1?-pyrido[3,4-b]indol]-2-one, and methods of administering in the treatment of malaria, in particular severe malaria
    Type: Application
    Filed: August 16, 2021
    Publication date: September 14, 2023
    Inventors: Priyanga Wickramanayake, Xueyan Wang, Henricus Lambertus Gerrardus Maria Tiemessen, Paolo De Marco, Akouavi Kéli Norbette Asso
  • Liposomal formulation for use in the treatment of cancer
    Patent number: 10722466
    Abstract: The invention relates to a pharmaceutical liposomal composition comprising 2-{[5-{3-chloro-2-methyl-4-[2-(4-methylpiperazin-1-yl)ethoxy]phenyl}-6-(4-fluorophenyl)thieno [2,3-d]pyrimidin-4-yl]oxy}-3-(2-{[2-(2-methoxyphenyl)pyrimidin-4-yl]methoxy}phenyl) propanoic acid, referred to herein as ‘Compound A’, or a pharmaceutically acceptable salt thereof. More specifically the invention relates to a liposomal vehicle, an organic concentrate composition comprising Compound A, and a pharmaceutical composition for parenteral administration comprising liposomes and Compound A. Furthermore, the invention relates to the use of such compositions for the treatment of cancer. ‘Compound A’ as used herein includes all enantiomers, diastereoisomers, and atropisomers thereof, or mixtures thereof, and also optionally includes the pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: October 27, 2017
    Date of Patent: July 28, 2020
    Assignees: LES LABORATOIRES SERVIER, NOVARTIS AG
    Inventors: Peter Wessels, Henricus Tiemessen, Paolo De Marco, Malika Larabi, Christiane Schiedel, Marina Gurina
  • LIPOSOMAL FORMULATION FOR USE IN THE TREATMENT OF CANCER
    Publication number: 20200054557
    Abstract: The invention relates to a pharmaceutical liposomal composition comprising 2-{[5-{3-chloro-2-methyl-4-[2-(4-methylpiperazin-1-yl)ethoxy]phenyl}-6-(4-fluorophenyl)thieno [2,3-d]pyrimidin-4-yl]oxy}-3-(2-{[2-(2-methoxyphenyl)pyrimidin-4-yl]methoxy}phenyl) propanoic acid, referred to herein as ‘Compound A’, or a pharmaceutically acceptable salt thereof. More specifically the invention relates to a liposomal vehicle, an organic concentrate composition comprising Compound A, and a pharmaceutical composition for parenteral administration comprising liposomes and Compound A. Furthermore, the invention relates to the use of such compositions for the treatment of cancer. ‘Compound A’ as used herein includes all enantiomers, diastereoisomers, and atropisomers thereof, or mixtures thereof, and also optionally includes the pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: October 27, 2017
    Publication date: February 20, 2020
    Inventors: Peter WESSELS, Henricus TIEMESSEN, Paolo DE MARCO, Malika LARABI, Christiane SCHIEDEL, Marina GURINA